戻る Agenda
Türkiye Townhall: Latest Developments and Opportunities Towards Greater International Regulatory Convergence
Session Chair(s)
Virginia Acha, PhD, MSc
AVP, Global Regulatory Policy
Merck Sharpe & Dohme LLC , United States
This Townhall will illustrate the opportunities and challenges facing a maturing regulatory authority. TITCK will address its ongoing adoption of ICH guidelines, its WHO Listed Agency procedure, and some novel regulatory legislations.
Learning Objective : • Illustrate TITCK latest developments towards greater international regulatory convergence • Discuss the challenges faced and opportunities for a maturing regulatory agency • Share lessons learnt from the WHO Listed Agency Review Procedure
Speaker(s)
Opportunities for Türkiye – the Industry Perspective
Nihan Burul Bozkurt, PhD
AIFD, Turkey
Health Policies Director
Handan Öztunca
Turkish Medicines and Medical Devices Agency (TITCK), Turkey
Head of Marketing Authorization Department
Inci Ergönül
Turkish Medicines and Medical Devices Agency (TITCK), Turkey
Head of Clinical Trials Department
Musa Ilker Durak
TITCK, Turkey
Deputy President
The Role of Turkish National Control Laboratories in the Regulatory and Supervisory System: Future Activity Plan and International Memberships
Serhat Aladag
TITCK , Turkey
Quality Manager